Demet Ozcan
Palle Juul Jensens Boulevard 99
Aarhus N, 8200, Denmark
Aarhus N, 8200, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.
Journal: The Lancet. Oncology
Published: January 11, 2026
Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial.
Journal: BMC cancer
Published: December 24, 2025
Immune Cell Composition and Prognosis in Node-Positive, Irradiated Breast Cancer Patients in the DBCG-IMN2 Study.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: September 25, 2025
Prognostic value of tumor-infiltrating lymphocytes in irradiated node-positive breast cancer patients.
Journal: Breast (Edinburgh, Scotland)
Published: May 05, 2025
Local recurrence with and without a tumour-bed boost: A post-hoc analysis of the DBCG IMN2 study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 09, 2025
Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study.
Journal: The Lancet regional health. Europe
Published: October 04, 2024
Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort.
Journal: Acta oncologica (Stockholm, Sweden)
Published: October 27, 2021
Can evaluation of mismatch repair defect and TILs increase the number of triple-negative breast cancer patients eligible for immunotherapy?
Journal: Pathology, research and practice
Published: February 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026